We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Neurology

ADHD and Risk of Late-Life Cognitive Impairment: Insights from Clinical and Genetic Data

MedXY Editorial Team•Oct 13, 2026•Neurology
ADHDcognitive impairmentDementiapolygenic risk score

Highlight

1. Adults diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) have over a fourfold increased risk of developing mild cognitive impairment (MCI) or dementia later in life compared to those without ADHD.

2. Genetic predisposition to ADHD, measured via polygenic risk scores (PRS), is independently associated with an elevated incidence of cognitive impairment, confirming a genetic liability link.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Enhancing Genetic Discovery in Sensorineural Hearing Loss Through Precision Audiometric PhenotypingPrecision phenotyping using audiometric pure-tone averages enhances genetic variant detection for sensorineural hearing loss compared to diagnostic coding, offering improved heritability estimates and risk prediction to advance hearing healOct 19, 2026Polygenic Risk Score Enhances Diagnosis and Prognostic Stratification in Idiopathic Pulmonary FibrosisA polygenic risk score (PRS) significantly associates with IPF diagnosis and mortality, demonstrating potential for improving clinical risk stratification using real-world biobank data.Oct 8, 2026Skin Denervation as a Biomarker Linked to Cognitive Decline and Brain Atrophy in Parkinson DiseasePeripheral skin nerve fiber loss correlates with cognitive impairment and brain atrophy in Parkinson disease, suggesting a peripheral-central neurodegenerative axis with potential diagnostic value.Oct 5, 2026Evolving Genetic Contributions to ASD and ADHD: Insights from Diagnosis Trends (1994–2016)
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Cardiology
Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
A Danish cohort study reveals decreased genetic risk profiles in recent ASD and ADHD diagnoses, supporting broader diagnostic criteria as a driver of rising incidence rates.
Sep 24, 2026
A Harmonized Visual Reading Framework for Tau PET Staging in Alzheimer DiseaseThis study introduces a standardized 5-class framework for tau PET imaging to better detect and stage Alzheimer’s disease, improving early diagnosis and patient stratification across different tracers.Sep 23, 2026
Retinal OCTA as a Window into Cerebral Small Vessel Disease and Cognitive Decline Post-StrokeThis longitudinal study shows that retinal microvascular changes measured by OCTA correspond with cerebral small vessel disease progression and cognitive decline in mild ischemic stroke patients, highlighting OCTA’s potential as a nonSep 20, 2026